Changjie Lou
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 12
- Inflammatory Biomarkers in Disease Prognosis 5
-
- Epigenetics and DNA Methylation 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Cancer Research and Treatments 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Journals
- Frontiers in Oncology (2 papers)Cancer Research and Treatment (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Changjie Lou
29 papers receiving 813 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 337
- Oncology 271
- Molecular Biology 468
- Immunology 123
- Pathology and Forensic Medicine 56
Countries citing papers authored by Changjie Lou
This map shows the geographic impact of Changjie Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjie Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjie Lou more than expected).
Fields of papers citing papers by Changjie Lou
This network shows the impact of papers produced by Changjie Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjie Lou. The network helps show where Changjie Lou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changjie Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 30 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 56 | |
| 14 | 2019 | 44 | |
| 15 | 2016 | 134 | |
| 16 | 2013 | 18 | |
| 17 | 2012 | 88 | |
| 18 | 2011 | 12 | |
| 19 | 2010 | 26 | |
| 20 | 2009 | 28 |
About Changjie Lou
Changjie Lou is a scholar working on Oncology, Cancer Research and Hepatology, having authored 33 papers that have together received 820 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Epigenetics and DNA Methylation (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Research and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (337 citations), Oncology (271 citations) and Molecular Biology (468 citations). Changjie Lou has collaborated with scholars based in China and United States. Frequent co-authors include Yanqiao Zhang, Min Xiao, Shenshan Jia, Shi Cheng, Xiaobo Lu, Zhiwei Li, Zhigang Ma, Juan Zhao, Shuli Tang and Yuanfei Yao. Their work appears in journals such as Frontiers in Oncology, Cancer Research and Treatment, International Journal of Biological Macromolecules, Frontiers in Cell and Developmental Biology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.